TSXV : COV.V

Covalon Technologies Ltd.

$2.18 CAD

$0 (0.0%)

Volume
3.2K
Average Volume
9.16K
Market Capitalization
$60.21M
P/E Ratio
36.52
Dividend Yield
6.88%
Price Target
Year High
$3.10
Year Low
$1.55
Day High
—
Day Low
—
Payout Ratio
$2.52
Current Ratio
$7.57
Company Overview

TSXV

Brent Ashton

Biotechnology

Healthcare

COV.V

105

CA

CAD

https://www.covalon.com

905 568 8400

22282D302

N/A

Liquidity Metrics

0.06

7.57

5.85

4.45

2.52

Sales & Valuation

$32.82M

1.84

2.15

12.89

0.17

Profitability

$0.0738

$2.06M

5.02%

5.02%

5.72%

4.95%

P/E Metrics

36.52

-0.64

-0.64

Analyst Price Target & Rating

Neutral

3/5

0 Analysts

%

Financial Health Scores

7.44

5/9

$24.43M

$33.18M

$5.16M

$1.14M

Key Metrics (TTM)

No key metrics data available.

Company Executives
Name Title
Saleha Assadzada Executive Assistant to the Chief Executive Officer
Greg Leszczynski Vice President of Human Resources
Hamed Abbasian Vice President of Business Development
Katie Martinovich Chief Financial Officer
Kimberley Crooks COO & Director
Gerry Arambula President of Covalon Technologies AG Ltd.
Brent Ashton Chief Executive Officer & Director
Valerio DiTizio Co-Founder, Chief Scientific Officer & Vice President
Poll Results

No votes yet today — be the first to share your view!

About Covalon Technologies Ltd. (TSXV:COV.V) Stock

Covalon Technologies Ltd., a Canadian company based in Mississauga, innovates, develops, manufactures, and commercializes medical technologies and products globally. Its operations span major international markets, including North America, Europe, the Middle East, Asia, and Latin America, with licensing agreements in place. The company leverages three distinct proprietary technology platforms. Firstly, its collagen matrix platform underpins a family of products aimed at treating a variety of chronic and infected wounds, such as diabetic, pressure, and venous ulcers, as well as donor and graft sites, traumatic injuries healing by secondary intention, dehisced surgical wounds, and first- and second-degree burns. Secondly, an antimicrobial silicone adhesive platform is incorporated into pre- ... and post-surgical and vascular access products; these are specifically engineered to provide broad-spectrum antimicrobial protection by eliminating bacteria or yeast on contact. Thirdly, a unique medical coating platform employs a proprietary photo-polymerization process to generate active grafting sites, enabling the initiation and growth of new polymer chains directly on existing medical devices. Covalon's product portfolio, branded under "Covalon," encompasses advanced wound care dressings, surgical and peri-operative solutions, and infection management tools. These offerings reach a diverse clientele, including hospitals, specialized wound and burn centers, acute and long-term care facilities, home health care agencies, and physicians' offices, via a combination of direct sales and extensive third-party distribution networks.

Frequently Asked Questions

What is the current Covalon Technologies Ltd. (COV.V) stock price?

Covalon Technologies Ltd.(TSXV:COV.V) stock price is $2.18 in the last trading session. During the trading session, COV.V stock reached the peak price of $3.1 while $1.55 was the lowest point it dropped to. The percentage change in COV.V stock occurred in the recent session was 0.0% while the dollar amount for the price change in COV.V stock was $0.

COV.V's industry and sector of operation?

The TSXV listed COV.V is part of Biotechnology industry that operates in the broader Healthcare sector.

Who are the executives of COV.V?

Saleha Assadzada | Executive Assistant to the Chief Executive Officer
Greg Leszczynski | Vice President of Human Resources
Hamed Abbasian | Vice President of Business Development
Katie Martinovich | Chief Financial Officer
Kimberley Crooks | COO & Director

How many employees does COV.V have?

Number of COV.V employees currently stands at 105. COV.V operates from 1660 Tech Avenue, Mississauga, ON L4W 5S7, CA.

Link for COV.V official website?

Official Website of COV.V is: https://www.covalon.com

How do I contact COV.V?

COV.V could be contacted at phone #905 568 8400 and can also be accessed through its website. COV.V operates from 1660 Tech Avenue, Mississauga, ON L4W 5S7, CA.

How many shares of COV.V are traded daily?

The average number of COV.V shares traded daily for last 3 months was 9.16K.

What is the market cap of COV.V currently?

The market value of COV.V currently stands at $60.21M with its latest stock price at $2.18